Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04688697

Prepectoral and Subpectoral Implant-based Breast Reconstruction

Breast cancer is one of the main malignant tumors threatening women's lives. In recent years, the increasing demand for reconstruction of breast cancer patients in China has made the proportion of breast reconstruction increase year by year, while implant reconstruction has become the most important way of breast reconstruction due to its less injury, shorter time of operation and relatively simple surgical technique. In the long-term clinical practice, due to the lack of safe and effective alternative methods, the reconstruction method with prosthesis placed to posterior pectoralis major has been accepted by surgeons and patients, and has become the most commonly used method of prosthesis construction. However, the development of biomaterials provides new ideas for breast reconstruction. At present, more and more doctors in clinical practice discontinue the use of serratus anterior, but use the synthetic mesh (mostly titanium mesh TiLoop® Bra) or allogeneic acellular dermal matrix mesh to cover part of the dilator or prosthesis so as to shorten the entire operation cycle and make the appearance of the reconstructed breast more natural and aesthetic. In particular, it can improve the contour of the folds under the breast and shape the breasts with a certain degree of sagging.

This study takes the patients receiving immediate reconstruction with an implant combined with TiLoop® Bra after total mastectomy as the subjects, aiming to compare the aesthetics and safety of the placement of implant to anterior and posterior pectoralis major through a prospective and randomized study. The primary objective of the study is to analyze the aesthetics of breast appearance, patient satisfaction and postoperative quality of life (QOL) of the placement of implant to anterior and posterior pectoralis major. The secondary objective of the study is to analyze the incidence of complications and type of reoperation in both groups.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Breast Carcinoma Breast Diseases Breast Neoplasms Breast Reconstruction Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Fudan University Shanghai Cancer Center

Shanghai, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • More than 18 years old
  • Female
  • Preoperative pathology confirming invasive breast carcinoma or ductal carcinoma in situ
  • Clinical T1 and T2 (Maximum tumor diameter ≤5 cm)
  • Clinical ALN negative (Clinical physical examination and ultrasound indicate axillary lymph node negative; Suspected abnormality of axillary lymph node, and fine needle aspiration negative)
  • No clinical or imaging evidence of distant metastasis
  • Patients to receive skin sparing mastectomy or nipple sparing mastectomy
  • BMI < 35
  • Patients with no or mild mastoptosis
  • Prosthesis to be implanted <500 ml
  • Be able and willing to sign the Informed Consent Form (ICF)

Exclusion criteria

  • Patients with the breast of moderate-severe mastoptosis, or requiring the use of Wise-pattern or other breast lift methods for subcutaneous mammary gland resection
  • BMI>=35
  • Patients who have received symmetrical breast surgery on the unaffected side immediately or later
  • Patients with locally advanced breast cancer to receive neoadjuvant therapy
  • Patients currently participating in other clinical trials, which may have impact on the participation in this trial
  • Neoadjuvant therapy has been completed, and there is clear indication of adjuvant radiotherapy after the operation
  • Previous history of breast cancer (patients with ipsilateral recurrence after breast sparing surgery)
  • Pregnancy breast-feeding women
  • History of smoking
  • Previous history of diabetes

Treatment and study plan

prepectoral implant-based reconstruction

Procedure

In this group, patients receive breast reconstruction with prosthesis placed to anterior pectoralis major, synthetic mesh is used to enclose the prosthesis and place it to anterior pectoralis major.

subpectoral implant-based reconstruction

Procedure

In this group, patients receive breast reconstruction with placed to posterior pectoralis major, part of the mesh is placed under the pectoralis major during the operation, and the mesh is used to cover the suture of the prosthesis on the inferior plica, or to directly enclose the lower part of the implant.

Primary outcomes

  1. Patients' satisfaction

    Time frame: 18 months after the operation

    Patients' satisfaction evaluated based on Breast-Q scale

Secondary outcomes

  1. Incidences of complications and serious complications

    Time frame: During 18 months after the operation

    Incidences of complications and serious complications

Sponsors and collaborators

Lead sponsor

Fudan University

Other

Registry information

Official study title

A Multicentric, Open-labeled, Prospective, Randomized Controlled Study to Compare the Satisfaction and Safety of the Prepectoral and Subpectoral Implant-based Breast Reconstruction in Patients Receiving Immediate Breast Reconstruction Using Implant Combined With TiLoop® Bra After Skin Sparing or Nipple-areola Sparing Mastectomy

Important dates

Study start
2021
Primary completion
2024
Study completion
2025
First posted
Dec 30, 2020
Registry last updated
Apr 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.